Publications for Aradhana Awasthi Tiwari
NYMC School of Medicine
Tiwari, A. A., Ayello, J., Van De Ven, C., Kurien, L., Barth, M. J., & Cairo, M. S. (2016). Antibody drug conjugates (anti-CD79b-vc-MMAE, polatuzumab vedotin) exhibit enhanced cell death targeted to CD79b+ burkitt lymphoma (BL) and primary mediastinal large B-cell lymphoma (PMBL). Cancer Research, 76(14 (Suppl)), 579. doi:10.1158/1538-7445.AM2016-579
Tiwari, A. A., Ayello, J., Van De Ven, C., Barth, M. J., & Cairo, M. S. (2014). Obinutuzumab (GA101) significantly increases overall survival against CD20+ rituximab-sensitive and-resistant Burkitt (BL) and acute lymphoblastic leukemia (B-ALL): Potential targeted therapy in patients with high risk BL and pre-B-ALL. Cancer Research, 74(19 Suppl.), 2902.
